PDCD4 expression in thyroid neoplasia

Virchows Archiv

Volumn 462, Issue 1, 2013, Pages 95-100

  Pennelli, Gianmaria ^a   Fassan, Matteo ^a   Mian, Caterina ^a   Pizzi, Marco ^a   Balistreri, Mariangela ^a   Barollo, Susi ^a   Galuppini, Francesca ^a   Guzzardo, Vincenza ^a   Pelizzo, Mariarosa ^a   Rugge, Massimo ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Immunohistochemistry; PDCD4; Thyroid cancer

Indexed keywords

MICRORNA 21; PROGRAMMED CELL DEATH 4 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; FOLLICULAR CARCINOMA; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; THYROID ADENOMA; THYROID CANCER; THYROID FOLLICLE CELL; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; ADULT; AGED; APOPTOSIS REGULATORY PROTEINS; CARCINOMA; CELL NUCLEUS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS; THYROID NEOPLASMS; UP-REGULATION; YOUNG ADULT;

EID: 84872297276     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-012-1352-6     Document Type: Article

References (22)

1. Ezzat S, Sarti DA, Cain DR et al (1994) Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med 154:1838-40
2. Burguera B, Gharib H (2000) Thyroid incidentalomas. Prevalence, diagnosis, significance, and management. Endocrinol Metab Clin North Am 29:187-203
3. Gharib H, Papini E, Valcavi R et al (2006) AACE/AME Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 12(1):63-102
4. DeLellis RA, Lloyd R, Heitz P (eds) (2004) World Health Organization classification of tumours. Pathology and genetics of tumours of endocrine organs. IARC, Lyon
5. Slough CM, Randolph GW (2006) Workup of well-differentiated thyroid carcinoma. Cancer Control 13(2):99-105
6. Giuffrida D, Gharib H (2000) Anaplastic thyroid carcinoma: current diagnosis and treatment. Ann Oncol 11(9):1083-9
7. Young MR, Santhanam AN, Yoshikawa N et al (2010) Have tumor suppressor PDCD4 and its counteragent oncogenic miR-21 gone rogue? Mol Interv 10(2):76-9
8. Allgayer H (2010) PDCD4, a colon cancer prognostic that is regulated by a microRNA. Crit Rev Oncol Hematol 73(3):185-91
9. Fassan M, Pizzi M, Battaglia G et al (2010) Programmed cell death 4 (PDCD4) expression during multistep Barrett's carcinogenesis. J Clin Pathol 63(8):692-6
10. Fassan M, Pizzi M, Giacomelli L et al (2011) PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis. Virchows Arch 458(4):413-9
11. Fassan M, Realdon S, Pizzi M et al (2012) Programmed cell death 4 nuclear loss and miR-21 or activated Akt overexpression in esophageal squamous cell carcinogenesis. Dis Esophagus 25(3):263-8
12. Mian C, Pennelli G, Fassan M et al (2012) microRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome. Thyroid 22(9):890-6
13. Fassan M, Cagol M, Pennelli G et al (2010) Programmed cell death 4 (PDCD4) protein in esophageal cancer. Oncol Rep 24:135-9
14. Rugge M, Fassan M, Clemente R et al (2008) Bronchopulmonary carcinoid: phenotype and long-term outcome in a single-institution series of Italian patients. Clin Cancer Res 14:149-54
15. Mudduluru G, Medved F, Grobholz R et al (2007) Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer. Cancer 110:1697-707
16. van Baal JW, Verbeek RE, Bus P et al (2012) microRNA-145 in Barrett's oesophagus: regulating BMP4 signalling via GATA6. Gut. doi: 10.1136/gutjnl-2011- 301061
17. Yamamichi N, Shimomura R, Inada K et al (2009) Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development. Clin Cancer Res 15:4009-16
18. Spires JR, Schwartz MR, Miller RH (1988) Anaplastic thyroid carcinoma. Association with differentiated thyroid cancer. Arch Otolaryngol Head Neck Surg 114(1):40-4
19. Cao Z, Yoon JH, Nam SW, Lee JY, Park WS (2012) PDCD4 expression inversely correlated with miR-21 levels in gastric cancers. J Cancer Res Clin Oncol 138(4):611-9
20. Jansen AP, Camalier CE, Colburn NH (2005) Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res 65:6034-41
21. Nieves-Alicea R, Colburn NH, Simeone AM et al (2009) Programmed cell death 4 inhibits breast cancer cell invasion by increasing tissue inhibitor of metalloproteinases-2 expression. Breast Cancer Res Treat 114:203-9
22. Chen Y, Knosel T, Kristiansen G et al (2003) Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. J Pathol 200:640-6